Related Experiment Video
Updated: Dec 22, 2025

07:01
An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
Published on: April 17, 2013
21.5K
Coexistence of Two Different Thyroid Malignancies: A Collision Phenomenon
Reza Pishdad1, Lissette Cespedes2, Regine Boutin1
1Internal Medicine, Rutgers New Jersey Medical School, Newark, USA.
Cureus
|May 8, 2020
Summary
This case report details a rare instance of simultaneous papillary thyroid carcinoma (PTC) and follicular thyroid carcinoma (FTC) in the same thyroid lobe. Management of such collision tumors requires individualized treatment due to their complex nature.
Area of Science:
- Endocrinology
- Oncology
- Pathology
Background:
- Collision tumors are defined as two or more distinct neoplastic morphologies coexisting in the same organ, separated by normal tissue.
- Simultaneous occurrence of papillary thyroid carcinoma (PTC) and follicular thyroid carcinoma (FTC) within the same thyroid lobe represents an exceptionally rare pathological entity.
- The management of thyroid collision tumors is often intricate due to the presence of diverse pathologies and limited existing literature.
Observation:
- A 79-year-old male presented with hip pain secondary to a lytic bone lesion, initially suspected to be metastatic follicular thyroid carcinoma (FTC).
- Subsequent imaging revealed an enlarged thyroid gland with a cystic lesion in the left lobe.
- Histopathological examination of the thyroid specimen confirmed the coexistence of two distinct primary malignancies: papillary thyroid carcinoma (PTC) and follicular thyroid carcinoma (FTC).
Findings:
- Histopathology confirmed the simultaneous presence of both papillary thyroid carcinoma (PTC) and follicular thyroid carcinoma (FTC) in the left thyroid lobe.
- Genetic analysis for RAS gene mutations yielded negative results.
- The patient was treated with total thyroidectomy, followed by levothyroxine suppression and radioactive iodine therapy.
Implications:
- This case highlights the rare phenomenon of simultaneous distinct thyroid neoplasms, suggesting potential simultaneous mutations in different genes.
- Individualized treatment strategies are crucial for managing complex thyroid collision tumors.
- Further research into the genetic underpinnings of coexisting thyroid carcinomas is warranted to understand their pathogenesis and optimize therapeutic approaches.
Related Concept Videos
The Thyroid Gland
6.4K
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
6.4K
Synthesis and Regulation of Thyroid Hormones
6.8K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
6.8K
Metastasis
6.3K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
Tumor Progression
7.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K
Cancers Originate from Somatic Mutations in a Single Cell
14.4K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.4K
Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K

